is proposing improvements to the EU Pharma Package. Underwritten Produced with financial support from an organization or individual, yet not approved by the underwriter before or after publication.

The pharmaceutical industry’s shift towards advanced secondary packaging is fueled by the need to ensure drug integrity and ...

Through a series of position papers, the EFPIA representing brandname drugmakers, self-medication group organisation AESGP, ...

Right incentives for meaningful innovations At the heart of the European Commission’s pharmaceutical package is the need to reconcile two goals: protecting innovation by pharmaceutical companies ...

Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), said there is nevertheless no getting away from the fact that the package reduces ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.